These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7150492)

  • 1. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
    Abratt RP
    Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of misonidazole on tumor cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro.
    Sakamoto K; Aritake S
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):825-30. PubMed ID: 7199475
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
    Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J; Hirst DG; Stewart FA; Terry NH
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the interval between administration of misonidazole and irradiation: an in vitro study.
    Hall EJ; Astor M
    Br J Cancer; 1982 Aug; 46(2):291-3. PubMed ID: 7150477
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
    Tenforde TS; Curtis SB; Parr SS; Afzal SM; Howard J; Lyman JT
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jun; 41(6):677-84. PubMed ID: 6981621
    [No Abstract]   [Full Text] [Related]  

  • 8. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP; Gulyas S; Whitmore GF
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
    Rasey JS; Krohn KA; Freauff S
    Radiat Res; 1982 Sep; 91(3):542-54. PubMed ID: 7122830
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
    Rofstad EK; Brustad T
    Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE; Stratford IJ; Edwards HS; Bremner JC; Cole S
    Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with hypoxic cell sensitizers-the European experience.
    Dische S
    Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.